Very good presentation. You're slowly making me redundant 🙈. At first glance, the company looks really good. Of course, it has the risk of the biotechnology sector. As recently seen with Corcept. $CORT. Very small in terms of market capitalization and therefore also a takeover fantasy
@Tenbagger2024 No, no, I can't make you redundant so quickly... But do you think the risk for a BioNTech company is really that great, because they've actually already had the therapy approved or this filter...? As far as I understand it, the FDA has approved it, or could they take it back?
@Klein-Anleger Corcept fell by more than 50% last week simply because the FDA requested further documentation on a drug. However, the company is in a solid position and already has drugs on the market. And studies are still ongoing. Nevertheless, such a price loss. But I don't want to scare you now. Just to show you the risk. But of course the chances of success are also very high
@Tenbagger2024 Just out of interest, how do you keep track of the current status of all the individual items? Somehow you have to find a balance between all the important but not too much useless information. What is the right approach?
@Il_Cavaliere You're probably right. I really need an intern. I would be happy to receive applications. But as an investor, I always like positive news. And by the time we small investors receive the negative news, the child has already fallen into the well anyway. And then reacting would often be wrong anyway. So it always helps to pray a lot. 🙈
